Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-18

Clinical Trial Update: Bioequivalence Study of Two Products of Tenofovir Alafenamide 25 mg Film Tablet in Healthy, Adult, Human Subjects [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study comparing two 25 mg tenofovir alafenamide film-coated tablet products in healthy adults has completed. The trial assessed bioequiva…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vemlidy (tenofovir alafenamide)

Snippet

Sponsor: Humanis Saglık Anonim Sirketi | Conditions: Chronic Hepatitis B in Adults and Paediatric Patients | Phase 1 | Status: COMPLETED